The protection triggered by AXL overexpression although not complete was equivalent to the one induced by PKCα or β (Figure 4) suggesting that AXL is one if not the main cause of resistance to IM in IM-R and PD-R CML cell lines. The gene discussed is AXL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.